Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed)

The summary for the Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed): This notice of funding opportunity (NOFO) is a limited competition notice of funding opportunity (NOFO) soliciting a cooperative agreement (U10) application from investigators currently supported under an existing study, entitled Collaborative Study on the Genetics of Alcoholism (COGA). The purpose of COGA is to identify genetic variants that affect the susceptibility to develop alcohol use disorder. The goals of this limited competition are to continue to advance the understanding of the complexity of the genotypes and phenotypes that contribute to the heterogeneity of AUD, integrate the analysis of multiple data sources, and generate mechanistic hypothesis to understand the contributions of genetic, behavioral, and environmental factors on the development of (or resilience from) AUD.

Federal Grant Title:	Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AA-24-003
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.273, 93.307
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 17th, 2024
Original Application Deadline:	March 17th, 2024
Posted Date:	February 14th, 2024
Creation Date:	February 14th, 2024
Archive Date:	April 22nd, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	February 14th, 2024

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Notice of Funding Opportunity for additional details on Eligibility
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-003.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Specialized Alcohol Research Centers (P50 Clinical trial Optional); • Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Stud...; • Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Stud...; • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional); • NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (...; • Mechanisms of Alcoholic Pancreatitis; • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies; • Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health: • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...; • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...